Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997019172) DIFFERENTIATION-SUPPRESSIVE POLYPEPTIDE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/019172 International Application No.: PCT/JP1996/003356
Publication Date: 29.05.1997 International Filing Date: 15.11.1996
Chapter 2 Demand Filed: 06.12.1996
IPC:
A61K 38/00 (2006.01) ,C07K 14/47 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
46
from vertebrates
47
from mammals
Applicants:
ASAHI KASEI KOGYO KABUSHIKI KAISHA [JP/JP]; 2-6, Dojimahama 1-chome Kita-ku Osaka-shi Osaka 530, JP (AllExceptUS)
SAKANO, Seiji [JP/JP]; JP (UsOnly)
ITOH, Akira [JP/JP]; JP (UsOnly)
Inventors:
SAKANO, Seiji; JP
ITOH, Akira; JP
Agent:
KOBAYASHI, Kazunori; Taiyoseimei-otsuka Building 3F 25-1, Kitaotsuka 2-chome Toshima-ku Tokyo 170, JP
Priority Data:
7/29961117.11.1995JP
7/31181130.11.1995JP
Title (EN) DIFFERENTIATION-SUPPRESSIVE POLYPEPTIDE
(FR) POLYPEPTIDE SUPPRESSEUR ET DE DIFFERENCIATION
Abstract:
(EN) A polypeptide which contains the amino acid sequence described in SEQ ID NO: 1 in the Sequence Listing encoded by a gene originating in human being. Because of serving as a chemical efficacious in the suppression of the proliferation and differentiation of undifferentiated blood cells, this polypeptide is expected to be usable in medicines and medical supplies.
(FR) Cette invention concerne un polypeptide contenant la séquence d'acide aminé décrite dans le N° ID SEQ: 1 de la liste de séquences, et codée par un gène provenant d'un être humain. Ce polypeptide peut être utilisé en qualité d'agent chimique efficace dans la suppression de la prolifération et la différenciation de cellules sanguines non différenciées, ce qui le rend utile dans des agents thérapeutiques et des produits médicaux.
Designated States: AU, CA, JP, US
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)
Also published as:
EP0861894US6337387US20020128197US20050130268US20050130271US20050164348
JP4283891CA2236679AU1996075876